These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26107180)

  • 1. Evidence for a Role of the Transcriptional Regulator Maid in Tumorigenesis and Aging.
    Fujisawa K; Terai S; Matsumoto T; Takami T; Yamamoto N; Nishina H; Furutani-Seiki M; Sakaida I
    PLoS One; 2015; 10(6):e0129950. PubMed ID: 26107180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maid (GCIP) is involved in cell cycle control of hepatocytes.
    Sonnenberg-Riethmacher E; Wüstefeld T; Miehe M; Trautwein C; Riethmacher D
    Hepatology; 2007 Feb; 45(2):404-11. PubMed ID: 17256742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
    Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
    Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of hepatocellular carcinoma biomarker, cyclase-associated protein 2 in zebrafish body development and cancer progression.
    Effendi K; Yamazaki K; Mori T; Masugi Y; Makino S; Sakamoto M
    Exp Cell Res; 2013 Jan; 319(1):35-44. PubMed ID: 23022774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.
    Wang Z; Yan J; Lin H; Hua F; Wang X; Liu H; Lv X; Yu J; Mi S; Wang J; Hu ZW
    Hepatology; 2013 May; 57(5):1869-81. PubMed ID: 23299825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescence marker protein 30 (SMP30)/regucalcin (RGN) expression decreases with aging, acute liver injuries and tumors in zebrafish.
    Fujisawa K; Terai S; Hirose Y; Takami T; Yamamoto N; Sakaida I
    Biochem Biophys Res Commun; 2011 Oct; 414(2):331-6. PubMed ID: 21951853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-specific androgen receptor knockout attenuates early liver tumor development in zebrafish.
    Li H; Li Y; Lu JW; Huo X; Gong Z
    Sci Rep; 2019 Jul; 9(1):10645. PubMed ID: 31337771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebrafish as a disease model for studying human hepatocellular carcinoma.
    Lu JW; Ho YJ; Yang YJ; Liao HA; Ciou SC; Lin LI; Ou DL
    World J Gastroenterol; 2015 Nov; 21(42):12042-58. PubMed ID: 26576090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
    Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
    Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vivo method for using 5-bromo-2'-deoxyuridine (BrdU) as a marker of chemically-induced hepatocellular proliferation in the Japanese medaka (Oryzias latipes).
    Brennan LM; Boncavage-Hennessey EM; Wolfe MJ; Toussaint MW; Dennis WE; Rosencrance AB; Gardner HS
    Toxicol Pathol; 2001; 29(3):387-97. PubMed ID: 11442025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible liver-specific overexpression of gankyrin in zebrafish results in spontaneous intrahepatic cholangiocarcinoma and hepatocellular carcinoma formation.
    Huang SJ; Cheng CL; Chen JR; Gong HY; Liu W; Wu JL
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1052-1058. PubMed ID: 28668389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive Notch2 signaling induces hepatic tumors in mice.
    Dill MT; Tornillo L; Fritzius T; Terracciano L; Semela D; Bettler B; Heim MH; Tchorz JS
    Hepatology; 2013 Apr; 57(4):1607-19. PubMed ID: 23175466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression.
    Li Z; Luo H; Li C; Huo X; Yan C; Huang X; Al-Haddawi M; Mathavan S; Gong Z
    Int J Cancer; 2014 Oct; 135(7):1564-73. PubMed ID: 24550086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
    Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maid is a negative regulator of transforming growth factor-β-induced cell migration.
    Motizuki M; Saitoh M; Miyazawa K
    J Biochem; 2015 Nov; 158(5):435-44. PubMed ID: 26002959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Males develop faster and more severe hepatocellular carcinoma than females in kras
    Li Y; Li H; Spitsbergen JM; Gong Z
    Sci Rep; 2017 Jan; 7():41280. PubMed ID: 28117409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression analysis on the dicyclanil-induced hepatocellular tumors in mice.
    Moto M; Okamura M; Muguruma M; Ito T; Jin M; Kashida Y; Mitsumori K
    Toxicol Pathol; 2006; 34(6):744-51. PubMed ID: 17162532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice.
    Yamamoto M; Tanaka H; Xin B; Nishikawa Y; Yamazaki K; Shimizu K; Ogawa K
    Mol Carcinog; 2017 Feb; 56(2):478-488. PubMed ID: 27253992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical inhibition reveals differential requirements of signaling pathways in kras
    Yan C; Yang Q; Huo X; Li H; Zhou L; Gong Z
    Sci Rep; 2017 Apr; 7():45796. PubMed ID: 28378824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained hepatic expression of FoxM1B in transgenic mice has minimal effects on hepatocellular carcinoma development but increases cell proliferation rates in preneoplastic and early neoplastic lesions.
    Kalinina OA; Kalinin SA; Polack EW; Mikaelian I; Panda S; Costa RH; Adami GR
    Oncogene; 2003 Sep; 22(40):6266-76. PubMed ID: 13679865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.